Loading
Cancer patients have had treatments delayed because basic chemotherapy drugs ran out. Keeping a national stockpile, like for flu antivirals, would prevent this.
Shortages of cisplatin, carboplatin, methotrexate, fluorouracil and other essential generics recur every few years in high-income countries and chronically in LMICs, usually after a single manufacturer's quality failure. Several countries hold strategic reserves of antivirals and antibiotics; none holds oncology essentials. The proposal is a rotating national or regional reserve covering six months of demand for the 20 most shortage-prone oncology generics, with stock rotated through normal supply chains to avoid waste, procurement rules that require dual sourcing, and automatic release triggers.
Shares Chemotherapy roadmap: mustard gas → curative combinations → the warhead inside smarter drugs, Most of the world has almost no cancer care, Paclitaxel / nab-paclitaxel, Platinum agents.
Shares The Repurposing Drugs in Oncology (ReDO) Project, Chemotherapy roadmap: mustard gas → curative combinations → the warhead inside smarter drugs, No incentive to repurpose cheap drugs, Most of the world has almost no cancer care.
Shares Chemotherapy roadmap: mustard gas → curative combinations → the warhead inside smarter drugs, No incentive to repurpose cheap drugs, Most of the world has almost no cancer care.
Shares The Repurposing Drugs in Oncology (ReDO) Project, No incentive to repurpose cheap drugs.
Shares The Repurposing Drugs in Oncology (ReDO) Project, No incentive to repurpose cheap drugs.
Shares The Repurposing Drugs in Oncology (ReDO) Project, No incentive to repurpose cheap drugs.
Shares The Repurposing Drugs in Oncology (ReDO) Project, No incentive to repurpose cheap drugs.
Shares The Repurposing Drugs in Oncology (ReDO) Project, No incentive to repurpose cheap drugs.